The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Pócsi, M.,
Fejes, Z.,
Bene, Z.,
Nagy, A. C.,
Balogh, I.,
Amaral, M. D.,
Macek, J. M.,
Nagy, B. J.:
Human epididymis protein 4 (HE4) plasma concentration inversely correlates with the improvement of cystic fibrosis lung disease in p.Phe508del-CFTR homozygous cases treated with the CFTR modulator lumacaftor/ivacaftor combination.
J. Cyst. Fibros. 22 (6), 1085-1092, 2023.
Bene, Z.,
Fejes, Z.,
Macek, J. M.,
Amaral, M. D.,
Balogh, I.,
Nagy, B. J.:
Laboratory biomarkers for lung disease severity and progression in cystic fibrosis.
Clin. Chim. Acta. 508, 277-286, 2020.
Nagy, B. J.,
Bene, Z.,
Fejes, Z.,
Heltshe, S. L.,
Reid, D. M.,
Ronan, N. J.,
McCarthy, Y.,
Smith, D.,
Nagy, A. C.,
Joseloff, E.,
Balla, G.,
Kappelmayer, J.,
Macek, J. M.,
Bell, S. C.,
Plant, B. J.,
Amaral, M. D.,
Balogh, I.:
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV1) in cystic fibrosis patients receiving ivacaftor treatment.
J. Cyst. Fibros. 18 (2), 271-277, 2019.
Papp, Á.,
Bene, Z.,
Gáspár, I. L.,
Nagy, B. J.,
Kádár, L.,
Marialigeti, T.,
Bánfi, A.,
Baktai, G.,
Balla, G.,
Nagy, B.:
Decreased VEGF Level Is Associated with Elevated Ferritin Concentration in Bronchoalveolar Lavage Fluid of Children with Interstitial Lung Diseases.
Respiration. 90 (6), 443-450, 2015.
